Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 2
1987 2
1989 1
1990 5
1991 3
1993 1
1994 1
1998 1
1999 2
2000 1
2001 2
2012 1
2015 1
2018 1
2021 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
[Rokitamycin in the treatment of female genital Chlamydia and Mycoplasma infections. Comparative study vs josamycin ].
Colombo U, Pifarotti G, Amidani M, Viezzoli T, Pifarotti P. Colombo U, et al. Minerva Ginecol. 1998 Nov;50(11):491-7. Minerva Ginecol. 1998. PMID: 9882991 Review. Italian.
Fifteen were given rokitamycin, 800 mg/day, and 15 josamycin, 1500 mg/day, for 14 days. In 13 cases in each group an antibiotic was prescribed for the partner too. At the start of the trial microbiological samples were taken; in 13 cases a urethral swab was taken (six in t …
Fifteen were given rokitamycin, 800 mg/day, and 15 josamycin, 1500 mg/day, for 14 days. In 13 cases in each group an antibiotic was p …
Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia.
Wenzel RP, Hendley JO, Dodd WK, Gwaltney JM. Wenzel RP, et al. Antimicrob Agents Chemother. 1976 Dec;10(6):899-901. doi: 10.1128/AAC.10.6.899. Antimicrob Agents Chemother. 1976. PMID: 795375 Free PMC article. Clinical Trial.
Twelve of 21 men treated with josamycin and 9 of 25 men treated with erythromycin had confirmed M. pneumoniae pneumonia. ...Fever days were similar for the josamycin-treated (1.4 +/- 0.4) and erythromycin-treated (1.2 +/- 0.3) groups (P = 0.95). ...
Twelve of 21 men treated with josamycin and 9 of 25 men treated with erythromycin had confirmed M. pneumoniae pneumonia. ...Fever day …
Efficacy and safety of clarithromycin versus josamycin in the treatment of hospitalized patients with bacterial pneumonia.
Straneo G, Scarpazza G. Straneo G, et al. J Int Med Res. 1990 Mar-Apr;18(2):164-70. doi: 10.1177/030006059001800211. J Int Med Res. 1990. PMID: 2140330 Clinical Trial.
Clinical success was reported for 91.5% of patients treated with clarithromycin and for 87.0% of those treated with josamycin. Eradication of the causative pathogen was noted in 85.7% of patients receiving clarithromycin and in 90% of those receiving josamycin. Adve …
Clinical success was reported for 91.5% of patients treated with clarithromycin and for 87.0% of those treated with josamycin. Eradic …
Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever.
Bella F, Font B, Uriz S, Muñoz T, Espejo E, Traveria J, Serrano JA, Segura F. Bella F, et al. Antimicrob Agents Chemother. 1990 May;34(5):937-8. doi: 10.1128/AAC.34.5.937. Antimicrob Agents Chemother. 1990. PMID: 2193627 Free PMC article. Clinical Trial.
We undertook a randomized clinical trial comparing therapeutic efficacy of the 1-day doxycycline regimen with the 5-day josamycin regimen for Mediterranean spotted fever. All 59 patients recovered uneventfully, and results did not significantly differ between the two sched …
We undertook a randomized clinical trial comparing therapeutic efficacy of the 1-day doxycycline regimen with the 5-day josamycin reg …
Comparative efficacy and tolerance of erythromycin and josamycin in the prevention of bacteraemia following dental extraction.
Sefton AM, Maskell JP, Kerawala C, Cannell H, Seymour A, Sun ZM, Williams JD. Sefton AM, et al. J Antimicrob Chemother. 1990 Jun;25(6):975-84. doi: 10.1093/jac/25.6.975. J Antimicrob Chemother. 1990. PMID: 2196261 Clinical Trial.
The tolerance and pharmacokinetics of erythromycin stearate and josamycin base were compared in healthy dental students. The efficacy and tolerance of the two antibiotics were compared in the prevention of bacteraemia following dental extraction. Erythromycin achieved high …
The tolerance and pharmacokinetics of erythromycin stearate and josamycin base were compared in healthy dental students. The efficacy …
A new quadruple therapy for Helicobacter pylori using tripotassium dicitrato bismuthate, furazolidone, josamycin and famotidine.
Liu WZ, Xiao SD, Hu PJ, Lu H, Cui Y, Tytgat GN. Liu WZ, et al. Aliment Pharmacol Ther. 2000 Nov;14(11):1519-22. doi: 10.1046/j.1365-2036.2000.00845.x. Aliment Pharmacol Ther. 2000. PMID: 11069324 Clinical Trial.
BACKGROUND: In our previous study, a triple therapy using tripotassium dicitrato bismuthate (TDB), josamycin and furazolidone achieved a suboptimal cure rate of Helicobacter pylori infection. ...CONCLUSIONS: One-week quadruple therapy consisting of TDB, furazolidone, jo …
BACKGROUND: In our previous study, a triple therapy using tripotassium dicitrato bismuthate (TDB), josamycin and furazolidone achieve …
Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis.
Fraschini F. Fraschini F. J Int Med Res. 1990 Mar-Apr;18(2):171-6. doi: 10.1177/030006059001800212. J Int Med Res. 1990. PMID: 2140331 Clinical Trial.
Clinical cures were experienced by 85% of the clarithromycin-treated patients, with an additional 10% showing improvement. In josamycin-treated patients, 76% of the patients experienced clinical cures and an additional 19% showed improvement. ...Adverse events, which all i …
Clinical cures were experienced by 85% of the clarithromycin-treated patients, with an additional 10% showing improvement. In josamycin …
[Azithromycin versus josamycin: treatment of 89 cases of acute pneumonia].
Aprim, Brion JP, Sedallian A, Le Noc P, Briffod J, Micoud M. Aprim, et al. Pathol Biol (Paris). 1990 Jun;38(5 ( Pt 2)):521-5. Pathol Biol (Paris). 1990. PMID: 2166934 Clinical Trial. French.
In an open, multicenter randomized clinical trial on patients with acute pneumonia, 5-day therapy using a new oral macrolide antibiotic, azithromycin (Az), was compared with standard 10-day therapy using another macrolide, josamycin (J). Eighty-nine patients were treated ( …
In an open, multicenter randomized clinical trial on patients with acute pneumonia, 5-day therapy using a new oral macrolide antibiotic, azi …
In vivo effects of josamycin, erythromycin, and placebo therapy on nasal carriage of Staphylococcus aureus.
Wilson SZ, Martin RR, Putman M. Wilson SZ, et al. Antimicrob Agents Chemother. 1977 Mar;11(3):407-10. doi: 10.1128/AAC.11.3.407. Antimicrob Agents Chemother. 1977. PMID: 324389 Free PMC article. Clinical Trial.
Healthy nasal carriers of Staphylococcus aureus were randomly assigned to one of three treatment regimens: josamycin (1.5 g/day), erythromycin stearate (1.0 g/day), or placebo, each administered orally for 7 days. ...All 25 placebo-treated subjects had positive nasal cultu …
Healthy nasal carriers of Staphylococcus aureus were randomly assigned to one of three treatment regimens: josamycin (1.5 g/day), ery …
26 results